Strategic Partnerships Sun Diagnostics offers customized, unassayed QC materials and interferents, creating opportunities to partner with clinical laboratories, contract research organizations, and diagnostic manufacturers that require tailored controls and reference materials for assay validation and interference testing.

Expansion Signals With a revenue range of 50 to 100 million and recent leadership happy in advancing R&D, there is potential to upsell broader assay QC kits, expanded interferent catalogs, and scalable solutions to support growing hematology, pharmacology, and proteomics testing workflows.

Quality & Compliance High quality interferents sourced from human materials or purified chemicals align with regulated lab environments; emphasize certifications, validation support, and regulatory-ready QC materials to win business from hospitals, reference labs, and biotech firms prioritizing compliance.

Technology Footprint Current tech stack and online presence suggest opportunities to digitally market QC solution bundles, subscription replenishment for kit materials, and self-service ordering for high-frequency customers in biotech and clinical diagnostics.

Market Positioning Smaller biotech supplier with a focused catalog can leverage speed, customization, and niche expertise to compete for mid-market lab accounts and specialty assay developers seeking flexible QC materials, offering faster onboarding and personalized support.